Study of MB-1 for weight and metabolic health in overweight adults
Part of Hormones & metabolism clinical trials.
This study tests a new supplement called MB-1 to see if it can improve metabolic health in adults who are overweight or obese. If you are between 18 and 50, have a certain waist size, and have been at a stable weight for the last 3 months, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your body mass index (BMI) is between 25.0 and 34.9.
- Your waist is larger than 37 inches (men) or 31.5 inches (women).
- You have not gained or lost more than 5% of your body weight in the last 3 months.
- You are willing to keep your current diet and lifestyle the same during the study.
- You are not pregnant, nursing, or planning to become pregnant, and you agree to use birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new approach to help with weight loss and body fat reduction. It may be a good fit if you are an adult with a BMI in the overweight to moderately obese range and you are not currently using weight-loss medications.
This study tests an investigational medication called MBX 4291 for adults with obesity. It aims to see if the drug is safe and how it works in the body, which could lead to a new weight-loss treatment option.
This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.
This trial tests a new tablet called MWN109 in healthy adults to see how safe it is and how the body handles it. It has two parts: one for people with a wide range of body weights, and another specifically for people with higher body weight. The results will help guide future studies.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
Hear when a new Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.